Denmark · Venture startup
2 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$42Mraised across 2 rounds since 2007, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Seventure Partners
Forbion Capital Partners
Sunstone Life Science Ventures
Gilde Healthcare
Global Life Science VenturesReported by pevc.dowjones.com
Seventure PartnersForbion Capital Partners
Omega FundsSunstone Life Science VenturesGilde HealthcareGlobal Life Science Ventures
Innovation Capital
BankInvestFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Santaris Pharma's investors include Seventure Partners, Forbion Capital Partners, Sunstone Life Science Ventures, Gilde Healthcare and Global Life Science Ventures, and 4 more on record.
Santaris Pharma has raised $42M across 2 rounds since 2007.
Santaris Pharma's most recent round was a Venture of $12M in Jun 2012.
Santaris Pharma's largest round on record is $30M (Series C), in Dec 2007.
Santaris Pharma's first round on record, in Dec 2007, was backed by Seventure Partners, Forbion Capital Partners and Omega Funds and 5 others.
Santaris Pharma's latest named round is a Venture, in Jun 2012.
Santaris Pharma is based in Denmark.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Denmark ·